Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis

被引：0
|
作者：
Maxwell J. Lasko
Holly K. Huse
David P. Nicolau
Joseph L. Kuti
机构：
[1] Hartford Hospital,Center for Anti
[2] Huntington Hospital,Infective Research and Development
[3] Hartford Hospital,Department of Clinical Microbiology
[4] Harbor-UCLA Medical Center,Division of Infectious Diseases
来源：
Annals of Clinical Microbiology and Antimicrobials | / 20卷
关键词：
Antibiotic resistance; Broth microdilution; Ceftazidime–avibactam; Ceftolozane–tazobactam;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] MIXED MORPHOTYPE SUSCEPTIBILITY TESTING OF PSEUDOMONAS-AERUGINOSA FROM CYSTIC-FIBROSIS PATIENTS
    SCHUTZE, GE
    LEWNO, MJ
    CLINICAL RESEARCH, 1993, 41 (04): : A738 - A738
  • [42] Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients
    Redero, Mar
    Lopez-Causape, Carla
    Aznar, Javier
    Oliver, Antonio
    Blazquez, Jesus
    Prieto, Ana I.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (10) : 2770 - 2776
  • [43] Typing of Pseudomonas aeruginosa in cystic fibrosis patients: comparison of genotype and antimicrobial susceptibility
    Tomic, Viktorija
    Ursic, Viktor
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2010, 79 (09): : 623 - 627
  • [44] COMPARISON OF INHIBITORY AND BACTERICIDAL ACTIVITY OF ANTIPSEUDOMONAL ANTIBIOTICS AGAINST PSEUDOMONAS-AERUGINOSA ISOLATES FROM CYSTIC-FIBROSIS PATIENTS
    ANSORG, R
    MULLER, KD
    WIORA, J
    CHEMOTHERAPY, 1990, 36 (03) : 222 - 229
  • [45] Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Balke, B
    Hogardt, M
    Schmoldt, S
    Hoy, L
    Weissbrodt, H
    Häussler, S
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (01) : 25 - 30
  • [46] Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients
    B. Balke
    M. Hogardt
    S. Schmoldt
    L. Hoy
    H. Weissbrodt
    S. Häussler
    European Journal of Clinical Microbiology and Infectious Diseases, 2006, 25 : 25 - 30
  • [47] Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis
    Dales, L.
    Ferris, W.
    Vandemheen, K.
    Aaron, S. D.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (10) : 1275 - 1279
  • [48] Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients
    Ballestero, S
    FernandezRodriguez, A
    Villaverde, R
    Escobar, H
    PerezDiaz, JC
    Baquero, F
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) : 39 - 45
  • [49] Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis
    L. Dales
    W. Ferris
    K. Vandemheen
    S. D. Aaron
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28 : 1275 - 1279
  • [50] Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa: Implications for patients with cystic fibrosis (CF)
    Millar, Beverley Cherie
    Malnarcic, Camila M.
    McCaughan, John
    Moore, John E.
    CLINICAL RESPIRATORY JOURNAL, 2020, 14 (01): : 64 - 68
12345